ASH 2018: Dr. Nicole Lamanna on combination therapies in CLL (chronic lymphocytic leukemia) Dr. Nicole Lamanna of Columbia University Irving Medical Center is a leading CLL researcher who gives us her broad overview... May 20, 20192018 ConferencesBy Brad Hedrick
ASH 2018: Dr. Pete Hillmen on the CLARITY trial of the combination of ibrutinib and venetoclax in relapsed or refractory CLL (chronic lymphocytic leukemia) Dr. Peter Hillmen out of Leeds has developed innovative research techniques to quickly advance the treatment options for CLL patients... May 13, 20192018 ConferencesBy Brad Hedrick
ASH 2018: Dr. Anthony Mato on a new Triple Combination of Novel Drugs for CLL and Richter’s Transformation The annual meeting of American Society of Hematology (ASH) 2018 is where new research is presented. Dr. Anthony Mato of Memorial... May 6, 20192018 ConferencesBy Brad Hedrick
ASH 2018: Dr. Kipps Updates on ROR1 Progress By Larry Marion This is the second part of the ASH 2018 interview with Dr. Kipps on targeted antibodies aimed at... April 28, 20192018 ConferencesBy Brad Hedrick
ASH 2018: Kipps on Venetoclax Outcomes Including Resistance—The “Whack a Mole” Challenge By Larry Marion Part one of two. Part two will be continued next week. Resistance is the scariest word in the English... April 21, 20192018 ConferencesBy Brad Hedrick
ERIC 2018: Kipps on Research Progress in Treating CLL (chronic lymphocytic leukemia) By Developing Antibodies That Control Key Proteins By Larry Marion This is the first of a series of three interviews with Dr. Thomas Kipps that will follow in... April 16, 20192018 ConferencesBy Brad Hedrick
ASH 2018: Dr. Siddiqi on the Practice Changing Lessons for Treating CLL The annual meeting of the American Society of Hematology or ASH is where the most important CLL research is presented... March 25, 20192018 ConferencesBy Brad Hedrick
ASH 2018: Dr. Woyach on ibrutinib with or without rituximab versus bendamustine plus rituximab By Brian Koffman, MD This is really big news. Practice changing news. Dr. Jennifer Woyach of Ohio State presented the results of... March 22, 20192018 ConferencesBy Brad Hedrick
ASH 2018: Dr. Furman on Limited Duration Novel Agents in CLL (chronic lymphocytic leukemia) It’s every chronic lymphocytic leukemia patient’s dream: Take some pills every day for a few years and you’re done with... March 18, 20192018 ConferencesBy Brad Hedrick
ASH 2018: Dr. Michael Hallek on Combination Therapy and More in CLL (chronic lymphocytic leukemia) Professor Michael Hallek leads the collaborative CLL German research group from his clinic in Cologne. Among other contributions, the research... March 3, 20192018 ConferencesBy Brad Hedrick
